Saxby Chambliss, Georgia’s senior U.S. senator, surprised the political world Friday when he announced he’s not running for a third term in 2014, despite recent claims he was ready to take on any and all challengers. The decision has several politicians and officeholders considering whether to run for the seat. In the meantime, PolitiFact Georgia thought we’d look back at how Chambliss has fared on our Truth-O-Meter.
All stories featuring Saxby Chambliss
Truthiness was in critical condition at PolitiFact Georgia last week. Our team published three fact checks in a row on health care. The first from presidential hopeful Herman Cain on CT scans flat-lined. One by U.S. Sen. Saxby Chambliss of Georgia on Internal Revenue Service agents and the health care overhaul was DOA. Another by U.S. Health and Human Services Secretary Kathleen Sebelius about hospital care survived and is in good condition. Even on issues outside of health care, truthiness looked at least a little bit puny. A claim by Donald Trump that the U.S. no longer builds bridges needed major surgery, as did a statement by MARTA’s chairman that the transit system is getting safer. Want to comment on our findings? Hit the "like" button on our Facebook page to join the discussion. You can also follow us on Twitter.
Thanks to recent battles over federal spending, the Truth-O-Meter hit a jackpot of claims that need checking. U.S. Sens. Saxby Chambliss of Georgia and Mark Warner of Virginia barnstormed the Atlanta area Monday to drum up support for reducing the national debt, so PolitiFact Georgia went for broke. We greeted them with rapid-fire fact checks. The budget hawks were mostly on the money. Warner won a True on Social Security data. Chambliss scored a Mostly True on debt growth figures and a Half True on how tax cuts impact tax revenue. MoveOn.org and U.S. Rep. Paul Broun of Athens shortchanged us on the facts. Both earned False rulings on the budget debate. Want to comment on our findings? Go to our Facebook page and hit the "like" button to join the discussion. You can also follow us on Twitter.